Ignite Creation Date:
2025-12-24 @ 12:49 PM
Ignite Modification Date:
2026-05-19 @ 10:55 AM
Study NCT ID:
NCT07168161
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2025-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Sponsor:
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ANCA Associated Vasculitis (AAV) | View |
Keywords: